Cadence Neuroscience

Redmond, United States

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

$26.0M raised

Feb 2023

Series B

Health Care Neuroscience Therapeutics

Top Investors

F-Prime Mayo Clinic LivaNova Jazz Venture Partners Angelini Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cadence Neuroscience

How much funding has Cadence Neuroscience raised?

Cadence Neuroscience has raised $26.0M in total funding. The most recent round was Series B. The last funding was announced in February 2023.

Who are Cadence Neuroscience's investors?

Cadence Neuroscience's investors include F-Prime, Mayo Clinic, LivaNova, Jazz Venture Partners, Angelini Ventures.

Where is Cadence Neuroscience headquartered?

Cadence Neuroscience is headquartered in Redmond, United States.

What does Cadence Neuroscience do?

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

What stage is Cadence Neuroscience at?

Cadence Neuroscience is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2023.

MLA

"Cadence Neuroscience — Funding & Investors." VCBacked, February 28, 2023, https://www.vcbacked.co/company/cadence-neuroscience. Accessed July 2, 2026.

APA

VCBacked. (2023). Cadence Neuroscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cadence-neuroscience

Wikipedia (cite web)

{{cite web |title=Cadence Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/cadence-neuroscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2023.